News Digest / Ticker: AMRX

Ticker: AMRX

05:15pm, Wednesday, May 07, 2025

Amneal Pharmaceuticals Reports Strong Q1 Recovery with $695.4M Revenue and $24.6M Net Income

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) Overview Amneal Pharmaceuticals, Inc. reported its financial results for the first quarter of 2025, showing a notable recovery from the previous year's challenging performance. The company operates through three main segments: Affordable Medicines, Specia...